(Q36322125)

13 August 2017

1 reference

title

Development of effective therapies against West Nile virus infection (English)

1 reference

13 August 2017

0 references

1

Michael S Diamond

0 references

publication date

1 December 2005

1 reference

Expert Review of Anti-infective Therapy

13 August 2017

1 reference

13 August 2017

3

1 reference

13 August 2017

6

1 reference

13 August 2017

931-944

1 reference

Nonviremic transmission of West Nile virus

13 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Argasid ticks as possible vectors of West Nile virus in Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Experimental transmission of West Nile virus (Flaviviridae: Flavivirus) by Carios capensis ticks from North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Ixodid and argasid tick species and west nile virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Morphologic and Molecular Characterization of New Cyclospora Species from Ethiopian Monkeys: C. cercopitheci sp.n., C. colobi sp.n., and C. papionis sp.n

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

West Nile virus: epidemiology and ecology in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Ocular manifestations of West Nile virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Neurologic manifestations and outcome of West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

West Nile encephalitis epidemic in southeastern Romania

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

The outbreak of West Nile virus infection in the New York City area in 1999

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Clinical characteristics of the West Nile fever outbreak, Israel, 2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Risk factors for West Nile virus infection and meningoencephalitis, Romania, 1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Transmission of West Nile Virus through Blood Transfusion in the United States in 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Detection of West Nile virus RNA and antibody in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Problem solved? West Nile virus and transfusion safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Emerging Infections, Transfusion Safety, and Epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

West Nile virus among blood donors in the United States, 2003 and 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

West Nile virus encephalitis in organ transplant recipients: another high-risk group for meningoencephalitis and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

A seroprevalence study of west nile virus infection in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Community-acquired West Nile virus infection in solid-organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Screening for West Nile virus in organ transplantation: a medical decision analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

West Nile virus: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Persistence of West Nile Virus (WNV) IgM antibodies in cerebrospinal fluid from patients with CNS disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

A Critical Role for Induced IgM in the Protection against West Nile Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Immunoassay Targeting Nonstructural Protein 5 To Differentiate West Nile Virus Infection from Dengue and St. Louis Encephalitis Virus Infections and from Flavivirus Vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Detection of human anti-flavivirus antibodies with a west nile virus recombinant antigen microsphere immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Persistence of virus-reactive serum immunoglobulin m antibody in confirmed west nile virus encephalitis cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Flavivirus genome organization, expression, and replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Interaction of West Nile virus with alpha v beta 3 integrin mediates virus entry into cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

The effect of pH on the early interaction of West Nile virus with P388D1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

The uncoating and infectivity of the flavivirus West Nile on interaction with cells: effects of pH and ammonium chloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Processing of flavivirus structural glycoproteins: stable membrane insertion of premembrane requires the envelope signal peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

A structural perspective of the flavivirus life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Structure of dengue virus: implications for flavivirus organization, maturation, and fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Structures of immature flavivirus particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Structure of West Nile Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Visualization of membrane protein domains by cryo-electron microscopy of dengue virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

A ligand-binding pocket in the dengue virus envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Dengue virus envelope glycoprotein structure: New insight into its interactions during viral entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Structure of the dengue virus envelope protein after membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Characterization of neutralizing antibodies to West Nile virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Identification of epitopes on the envelope (E) protein of dengue 2 and dengue 3 viruses using monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Japanese encephalitis virus antigenic variants with characteristic differences in neutralization resistance and mouse virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Localization of a neutralizing epitope on the envelope protein of dengue virus type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Structural basis of West Nile virus neutralization by a therapeutic antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of the domain III of the Japanese encephalitis virus envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Human dendritic cells as targets of dengue virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Human skin Langerhans cells are targets of dengue virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Langerhans cells migrate to local lymph nodes following cutaneous infection with an arbovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Pathogenesis of Viral Infections of the Nervous System

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Pathogenesis of viral infections of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

West Nile virus: crossing the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

21 January 2018

West Nile poliomyelitis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Poliomyelitis due to West Nile virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

A poliomyelitis-like syndrome from West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Infection and injury of neurons by West Nile encephalitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Induction of inflammation by West Nile virus capsid through the caspase-9 apoptotic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Langat Flavivirus Protease NS3 Binds Caspase-8 and Induces Apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Infection with Langat Flavivirus or expression of the envelope protein induces apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Immunity to West Nile virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Innate and Adaptive Immune Responses Determine Protection against Disseminated Infection by West Nile Encephalitis Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Role of CD8+ T cells in control of West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Exocytosis and Fas mediated cytolytic mechanisms exert protection from West Nile virus induced encephalitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Complement activation is required for induction of a protective antibody response against West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Low resolution mapping around the flavivirus resistance locus (Flv) on mouse chromosome 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Positional cloning of the murine flavivirus resistance gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

A nonsense mutation in the gene encoding 2'-5'-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Lassa fever. Effective therapy with ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Treatment of severe La Crosse encephalitis with intravenous ribavirin following diagnosis by brain biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Error-prone replication of West Nile virus caused by ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Efficacy of Interferon -2b and Ribavirin Against West Nile Virus In Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Prophylactic ribavirin treatment of dengue type 1 infection in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Polymerase substrate depletion: a novel strategy for inhibiting the replication of the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Mycophenolic acid, an immunosuppressive agent, inhibits HBV replication in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Mycophenolate mofetil strongly potentiates the anti-herpesvirus activity of acyclovir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Identification of active antiviral compounds against a New York isolate of West Nile virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Antiviral actions of interferon interferon-regulated cellular proteins and their surprisingly selective antiviral activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

The host response to West Nile Virus infection limits viral spread through the activation of the interferon regulatory factor 3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Inhibition of interferon signaling by dengue virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Inhibition of Alpha/Beta Interferon Signaling by the NS4B Protein of Flaviviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Interferon-alpha protects mice against lethal infection with St Louis encephalitis virus delivered by the aerosol and subcutaneous routes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Effect of interferon-alpha2b therapy on St. Louis viral meningoencephalitis: clinical and laboratory results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Antibodies for the prevention and treatment of viral diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Immune response to synthetic peptides of dengue prM protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Recombinant baculoviruses expressing yellow fever virus E and NS1 proteins elicit protective immunity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Cell surface expression of yellow fever virus non-structural glycoprotein NS1: consequences of interaction with antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Neutralizing F(ab')2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Synergistic Interactions of Anti-NS1 Monoclonal Antibodies Protect Passively Immunized Mice from Lethal Challenge with Dengue 2 Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2b

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Protection against tick-borne encephalitis virus isolated in Japan by active and passive immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Passive immunization of mice with monoclonal antibodies raised against tick-borne encephalitis virus. Brief report

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Immunisation with gamma globulin to murray valley encephalitis virus and with an inactivated Japanese encephalitis virus vaccine as prophylaxis against australian encephalitis: evaluation in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Antibody-mediated enhancement of Flavivirus replication in macrophage-like cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Complement receptor mediates enhanced flavivirus replication in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Flavivirus Infection Enhancement in Macrophages: Radioactive and Biological Studies on the Effect of Antibody on Viral Fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Flavivirus infection enhancement in macrophages: an electron microscopic study of viral cellular entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Antibody-mediated early death in vivo after infection with yellow fever virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Immune enhancement of yellow fever virus neurovirulence for mice: studies of mechanisms involved

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Antibody-dependent enhancement of yellow fever and Japanese encephalitis virus neurovirulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Treatment of West Nile virus-infected mice with reactive immunoglobulin reduces fetal titers and increases dam survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Gene silencing as an adaptive defence against viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Induction and suppression of RNA silencing: insights from viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Assembly and function of RNA silencing complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

RNA interference is mediated by 21- and 22-nucleotide RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Stable suppression of gene expression by RNAi in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

A DNA vector-based RNAi technology to suppress gene expression in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

The utility of siRNA transcripts produced by RNA polymerase i in down regulating viral gene expression and replication of negative- and positive-strand RNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Use of RNA interference to prevent lethal murine west nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Short interfering RNA confers intracellular antiviral immunity in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

RNA silencing in viral infections: insights from poliovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Modulation of HIV-1 replication by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

RNA interference in adult mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Inhibition of hepatitis B virus in mice by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Small interfering RNA Inhibits Hepatitis B virus replication in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Protection against lethal influenza virus challenge by RNA interference in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Inhibition of influenza virus production in virus-infected mice by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Use of siRNAs to prevent and treat influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Synthetic oligonucleotides as therapeutics: the coming of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Inhibition of dengue virus serotypes 1 to 4 in vero cell cultures with morpholino oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Antisense morpholino-oligomers directed against the 5' end of the genome inhibit coronavirus proliferation and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

A spring-loaded mechanism for the conformational change of influenza hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

HIV-1 entry inhibitors in the side pocket

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

A synthetic peptide from a heptad repeat region of herpesvirus glycoprotein B inhibits virus replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

The Fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Peptide inhibitors of dengue virus and West Nile virus infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

Monoclonal antibodies against the flavivirus West Nile

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.931

21 January 2018

Identifiers

DOI

10.1586/14787210.3.6.931

1 reference

13 August 2017

1 reference

PubMed ID

16307506